These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 27547944)

  • 21. Synergy between the pay-for-performance scheme and better physician-patient relationship might reduce the risk of retinopathy in patients with type 2 diabetes.
    Chiou SJ; Liao K; Huang YT; Lin W; Hsieh CJ
    J Diabetes Investig; 2021 May; 12(5):819-827. PubMed ID: 33025682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of pay for performance on risk incidence of infection and of revision after total knee arthroplasty in type 2 diabetic patients: A nationwide matched cohort study.
    Tsai YS; Kung PT; Ku MC; Wang YH; Tsai WC
    PLoS One; 2018; 13(11):e0206797. PubMed ID: 30388167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of pay-for-performance on mortality in diabetes patients in Taiwan: A population-based study.
    Chen YC; Lee CT; Lin BJ; Chang YY; Shi HY
    Medicine (Baltimore); 2016 Jul; 95(27):e4197. PubMed ID: 27399144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of Pay-for-Performance Incentive Designs on Diabetes Care.
    Hsieh HM; Shin SJ; Tsai SL; Chiu HC
    Med Care; 2016 Dec; 54(12):1063-1069. PubMed ID: 27479599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-Term and Interactive Effects of Pay-For-Performance Interventions among Diabetic Nephropathy Patients at the Early Chronic Kidney Disease Stage.
    Liao PJ; Lin TY; Wang TC; Ting MK; Wu IW; Huang HT; Wang FC; Chang HC; Hsu KH
    Medicine (Baltimore); 2016 Apr; 95(14):e3282. PubMed ID: 27057892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of a PPO pay-for-performance program on patients with diabetes.
    Chen JY; Tian H; Taira Juarez D; Hodges KA; Brand JC; Chung RS; Legorreta AP
    Am J Manag Care; 2010 Jan; 16(1):e11-9. PubMed ID: 20059287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-Effectiveness of a Diabetes Pay-For-Performance Program in Diabetes Patients with Multiple Chronic Conditions.
    Hsieh HM; Gu SM; Shin SJ; Kao HY; Lin YC; Chiu HC
    PLoS One; 2015; 10(7):e0133163. PubMed ID: 26173086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does Pay-For-Performance Program Increase Providers Adherence to Guidelines for Managing Hepatitis B and Hepatitis C Virus Infection in Taiwan?
    Chen HJ; Huang N; Chen LS; Chou YJ; Li CP; Wu CY; Chang YC
    PLoS One; 2016; 11(8):e0161002. PubMed ID: 27517172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does enhanced diabetes management reduce the risk and improve the outcome of tuberculosis?
    Lo HY; Yang SL; Lin HH; Bai KJ; Lee JJ; Lee TI; Chiang CY
    Int J Tuberc Lung Dis; 2016 Mar; 20(3):376-82. PubMed ID: 27046720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of Nationwide COPD Pay-for-Performance Program on COPD Exacerbations in Taiwan.
    Cheng SL; Li YR; Huang N; Yu CJ; Wang HC; Lin MC; Chiu KC; Hsu WH; Chen CZ; Sheu CC; Perng DW; Lin SH; Yang TM; Lin CB; Kor CT; Lin CH
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2869-2881. PubMed ID: 34703221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pay-for-performance for shared care of diabetes in Taiwan.
    Lee IT; Hsu CC; Sheu WH; Su SL; Wu YL; Lin SY
    J Formos Med Assoc; 2019 Nov; 118 Suppl 2():S122-S129. PubMed ID: 31471222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A longitudinal examination of a pay-for-performance program for diabetes care: evidence from a natural experiment.
    Cheng SH; Lee TT; Chen CC
    Med Care; 2012 Feb; 50(2):109-16. PubMed ID: 22249920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Merging P4P and disease management: how do you know which one is working?
    Smith AL
    J Manag Care Pharm; 2007 Mar; 13(2 Suppl B):S7-10. PubMed ID: 17341140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of pay-for-performance for primary care physicians on diabetes outcomes in single-payer health systems: a systematic review.
    Gupta N; Ayles HM
    Eur J Health Econ; 2019 Dec; 20(9):1303-1315. PubMed ID: 31401699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using financial incentives to improve the care of tuberculosis patients.
    Lee CY; Chi MJ; Yang SL; Lo HY; Cheng SH
    Am J Manag Care; 2015 Jan; 21(1):e35-42. PubMed ID: 25880266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association of clinical guideline adherence and pay-for-performance among patients with diabetes.
    Lai CL; Hou YH
    J Chin Med Assoc; 2013 Feb; 76(2):102-7. PubMed ID: 23351421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pay-for-performance program for diabetes care in Taiwan: a preliminary assessment.
    Lee TT; Cheng SH; Chen CC; Lai MS
    Am J Manag Care; 2010 Jan; 16(1):65-9. PubMed ID: 20148607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Diabetes Pay-for-Performance Program and Risks of Cancer Incidence and Death in Patients With Type 2 Diabetes in Taiwan.
    Hsieh HM; He JS; Shin SJ; Chiu HC; Lee CT
    Prev Chronic Dis; 2017 Oct; 14():E88. PubMed ID: 28981404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Examining the Long-term Spillover Effects of a Pay-for-Performance Program in a Healthcare System That Lacks Referral Arrangements.
    Chen CC; Chien KL; Cheng SH
    Int J Health Policy Manag; 2023; 12():7571. PubMed ID: 38618790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A nationwide cohort investigation on pay-for-performance and major adverse limb events in patients with diabetes.
    Lu CW; Wu YF; Chen TH; Chung CM; Lin CL; Lin YS; Chen MY; Yang YH; Lin MS
    Prev Med; 2021 Dec; 153():106787. PubMed ID: 34506818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.